CERE - M&A activity expected to pick up in 2024 bankers say
2023-12-24 09:11:28 ET
More on Bristol-Myers Squibb Company , Karuna Therapeutics, etc.
- Bristol-Myers Squibb: Too Many Headwinds To Ignore, Despite The Stellar
- Bristol Myers Squibb: Aggressive M&A, A Riskier Strategy To Fix The Growth Challenge
- Bristol Myers Squibb: This Dividend Contender Is A Steal Right Now
- Biggest stock movers today: Ansys, Rocket Lab, Nike, Cummins, NetEase and more
- Bristol-Karuna deal: What other biotechs might be in M&A crosshairs?
For further details see:
M&A activity expected to pick up in 2024, bankers say